Tiziana Life Sciences submits request to FDA for orphan drug designation for intranasal foralumab for MSA
TLSA•Tiziana Life Sciences submitted a request to the FDA for orphan drug designation for intranasal foralumab for MSA.
1. FDA designation request
Tiziana Life Sciences submitted a request to the FDA for orphan drug designation for intranasal foralumab for MSA.
